Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

Mise à jour : Il y a 4 ans
Référence : NCT00134511

Femme et Homme

Extrait

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To evaluate the efficacy and safety of the lipid drug Torcetrapib/atorvastatin in patients with genetically known disorder of extremely high cholesterol


Critère d'inclusion

  • Hypercholesterolemia, Familial

Liens